News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Caution on robotic surgery from Ob/Gyn group. FDA gets closer to gaining access to most of fiscal 2013 user fees. More news.
You may also be interested in...
Research Briefs: Updates From EndoGastric Solutions, Cordis, Aptus Endosystems
RESPECT trial is designed to provide the kind of Level 1 evidence EndoGastic Solutions needs to persuade payers and physicians of the benefits of the EsophyX GERD-repair device. Cordis and Aptus Endosystems release new data at the Vascular Interventional Advances (VIVA) 2013 annual meeting in Las Vegas.
Pressure On Hysterectomy Procedures Challenges Intuitive’s Financials
The robotic surgical instrument company attributes the decline in capital equipment sales to disappointing growth in benign gynecology procedures performed in the U.S. with the firm’s flagship da Vinci robot.
News In Brief
Senate symbolically votes to repeal device tax. Sequester will take about 5 percent from device user fees. More news in brief.